Generic Drug Products in Paediatrics: Where Are the Data?
Document Type
Editorial
Publication Date
9-2019
Abstract
The use of generic drugs can significantly decrease costs while providing equivalent therapeutic efficacy, thus increasing access to medications. This can be of special interest for some high‐cost medications and those used in chronic therapy (eg, immunosuppressive agents, oncology drugs, and antiepileptic drugs). The Food and Drug Administration (FDA) defines a generic drug as being “the same as a brand name drug in dosage, safety, strength, how it is taken, quality, performance, and intended use.”1
Repository Citation
Illamola, S. M.,
Birnbaum, A.,
& Sherwin, C. M.
(2019). Generic Drug Products in Paediatrics: Where Are the Data?. British Journal of Clinical Pharmacology, 85 (9), 1871-1873.
https://corescholar.libraries.wright.edu/pediatrics/363
DOI
10.1111/bcp.14036